{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:27:59Z","timestamp":1774542479621,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.intimp.2020.107229","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T10:04:18Z","timestamp":1613901858000},"page":"107229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Indirubin attenuates IL-17A-induced CCL20 expression and production in keratinocytes through repressing TAK1 signaling pathway"],"prefix":"10.1016","volume":"94","author":[{"given":"Jingxia","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangjiang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Di","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoxia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2020.107229_b0005","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","article-title":"Psoriasis pathogenesis and the development of novel targeted immune therapies","volume":"140","author":"Hawkes","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107229_b0010","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2340\/00015555-3066","article-title":"The keratinocyte transcriptome in psoriasis: pathways related to immune responses, cell cycle and keratinization","volume":"99","author":"Pasquali","year":"2019","journal-title":"Acta Derm. Venerol."},{"key":"10.1016\/j.intimp.2020.107229_b0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-3-319-41342-6_12","article-title":"The role of indirubins in inflammation and associated tumorigenesis","volume":"929","author":"Cheng","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2020.107229_b0020","first-page":"319","article-title":"A review of indigo naturalis as an alternative treatment for nail psoriasis","volume":"15","author":"McDermott","year":"2016","journal-title":"J. Drugs Dermatol."},{"issue":"6","key":"10.1016\/j.intimp.2020.107229_b0025","first-page":"652","article-title":"Indigo Naturalis in the treatment of Psoriasis","volume":"18","author":"Wang","year":"2019","journal-title":"Chinese J. Dermatovenereol. Integrated Traditional Western Med."},{"issue":"2","key":"10.1016\/j.intimp.2020.107229_b0030","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jdermsci.2012.05.008","article-title":"Indirubin, an acting component of indigo naturalis, inhibits EGFR activation and EGF-induced CDC25B gene expression in epidermal keratinocytes","volume":"67","author":"Hsieh","year":"2012","journal-title":"J. Dermatol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2020.107229_b0035","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180958","article-title":"Indirubin attenuates mouse psoriasis-like skin lesion in a CD274-dependent manner: an achievement of RNA sequencing","volume":"38","author":"Xue","year":"2018","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2020.107229_b0040","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jdermsci.2011.10.001","article-title":"Attenuation of psoriasis-like skin lesion in a mouse model by topical treatment with indirubin and its derivative E804","volume":"65","author":"Miyoshi","year":"2012","journal-title":"J. Dermatol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2020.107229_b0045","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jep.2012.11.044","article-title":"Indigo naturalis upregulates claudin-1 expression in human keratinocytes and psoriatic lesions","volume":"145","author":"Lin","year":"2013","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2020.107229_b0050","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/bjd.16807","article-title":"A traditional Chinese remedy points to a natural skin habitat: indirubin (indigo naturalis) for psoriasis and the Malassezia metabolome","volume":"179","author":"Gaitanis","year":"2018","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.intimp.2020.107229_b0055","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/bjd.15894","article-title":"Comparison of indirubin concentrations in indigo naturalis ointment for psoriasis treatment: a randomized, double\u2010blind, dosage\u2010controlled trial","volume":"178","author":"Lin","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.intimp.2020.107229_b0060","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.molimm.2018.07.011","article-title":"Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing \u03b3\u03b4 T cells","volume":"101","author":"Xie","year":"2018","journal-title":"Mol. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107229_b0065","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/jid.2014.383","article-title":"Syk mediates IL-17-induced CCL20 expression by targeting Act1-dependent K63-linked ubiquitination of TRAF6","volume":"135","author":"Wu","year":"2015","journal-title":"J. Invest. Dermatol."},{"issue":"11","key":"10.1016\/j.intimp.2020.107229_b0070","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/ni1255","article-title":"Essential function for the kinase TAK1 in innate and adaptive immune responses","volume":"6","author":"Sato","year":"2005","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107229_b0075","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3390\/ijms17020244","article-title":"Therapeutic effects of erythroid differentiation regulator 1 on imiquimod-induced psoriasis-like skin inflammation","volume":"17","author":"Kim","year":"2016","journal-title":"IJMS"},{"key":"10.1016\/j.intimp.2020.107229_b0080","unstructured":"World health organization. Global report on psoriasis, 2016, 2016. pp. 7-9."},{"issue":"4","key":"10.1016\/j.intimp.2020.107229_b0085","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3390\/ijms21041275","article-title":"Interleukin-17A and Keratinocytes in Psoriasis","volume":"21","author":"Furue","year":"2020","journal-title":"IJMS"},{"issue":"4","key":"10.1016\/j.intimp.2020.107229_b0090","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/imm.12993","article-title":"Interleukin-17-producing \u03b3\u03b4 T (\u03b3\u03b4 17) cells in inflammatory diseases","volume":"155","author":"Akitsu","year":"2018","journal-title":"Immunology"},{"issue":"269","key":"10.1016\/j.intimp.2020.107229_b0095","doi-asserted-by":"crossref","first-page":"269rv1","DOI":"10.1126\/scitranslmed.3010641","article-title":"Resident memory T cells in human health and disease","volume":"7","author":"Clark","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2020.107229_b0100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00281-015-0539-8","article-title":"Update on psoriasis immunopathogenesis and targeted immunotherapy","volume":"38","author":"Mahil","year":"2016","journal-title":"Semin. Immunopathol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107229_b0105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/cei.13449","article-title":"IL\u201017 in inflammatory skin diseases psoriasis and hidradenitis suppurativa","volume":"201","author":"Fletcher","year":"2020","journal-title":"Clin. Exp. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2020.107229_b0110","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1517\/14728222.2010.504716","article-title":"CCR6 as a possible therapeutic target in psoriasis","volume":"14","author":"Hedrick","year":"2010","journal-title":"Expert Opinion Therapeutic Targets"},{"issue":"27","key":"10.1016\/j.intimp.2020.107229_b0115","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1038\/onc.2014.286","article-title":"Th17-type cytokines, IL-6 and TNF-\u03b1 synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth","volume":"34","author":"De Simone","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2020.107229_b0120","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cellsig.2017.01.006","article-title":"Nuclear translocation of STAT3 and NF-\u03baB are independent of each other but NF-\u03baB supports expression and activation of STAT3","volume":"32","author":"Martincuks","year":"2017","journal-title":"Cell. Signal."},{"issue":"9","key":"10.1016\/j.intimp.2020.107229_b0125","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.1074\/jbc.272.9.5846","article-title":"Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver: chemotactic activity for lymphocytes and gene localization on chromosome 2","volume":"272","author":"Hieshima","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2020.107229_b0130","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12846","article-title":"The CCL20 and CCR6 axis in psoriasis","volume":"91","author":"Furue","year":"2020","journal-title":"Scand. J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2020.107229_b0135","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.yexcr.2010.12.018","article-title":"CCR6 as a mediator of immunity in the lung and gut","volume":"317","author":"Ito","year":"2011","journal-title":"Exp. Cell Res."},{"issue":"3","key":"10.1016\/j.intimp.2020.107229_b0140","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.imbio.2019.01.005","article-title":"The CCR6-CCL20 axis in humoral immunity and T-B cell immunobiology","volume":"224","author":"Lee","year":"2019","journal-title":"Immunobiology"},{"issue":"12","key":"10.1016\/j.intimp.2020.107229_b0145","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.4049\/jimmunol.164.12.6621","article-title":"Up-regulation of macrophage inflammatory protein-3 alpha\/CCL20 and CC chemokine receptor 6 in psoriasis","volume":"164","author":"Homey","year":"2000","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2020.107229_b0150","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1365-2230.2004.01638.x","article-title":"Homing receptor and chemokine receptor on intraepidermal T cells in psoriasis vulgaris","volume":"29","author":"Teraki","year":"2004","journal-title":"Clin. Exp. Dermatol."},{"issue":"5","key":"10.1016\/j.intimp.2020.107229_b0155","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/medicina54050088","article-title":"Modulation of the CCR6-CCL20 axis: a potential therapeutic target in inflammation and cancer","volume":"54","author":"Ranasinghe","year":"2018","journal-title":"Medicina"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920336961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920336961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:31:36Z","timestamp":1761586296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920336961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":31,"alternative-id":["S1567576920336961"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107229","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indirubin attenuates IL-17A-induced CCL20 expression and production in keratinocytes through repressing TAK1 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107229"}}